 |
 |
One of our Rheumatologists who reads more than I do has asked for an availability and costing for Anti-CPP as a rheumatological marker (see attached pdf). Does anyone have a laboratory line on this please ? with best wishes Richard Richard Mainwaring-Burton Consultant Biochemist Queen Mary's Hospital Sidcup, Kent DA14 6LT 020-8308-3084 http://website.lineone.net/~andrewbamji/index.htm -----Original Message----- From: yasser elmiedany [mailto:[log in to unmask]] Sent: 04 December 2003 15:47 To: Andrew Bamji Subject: Re: Anit-CCP Dear Andrew. thank you for your email. Over the past year (2002) several research studies were published about early arthritis and how to manage it. Some of the studies were conducted in UK by David Scott and Paul Emery. Separate supplements have been published in J. Rheumatology, Clinical and Experimental Rheumatology discussing that issue in review articles. Anti-CCP has been found more specific than RF from the diagnostic point of view and better in predicting the course of arthritis, specially early arthritis. Please find attached a small and quick review published by the American College of Rheumatology on 3rd of October 03. I look forward to seeing you. Kind regards Yasser ------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/